MISSISSAUGA, Ontario, September 16, 2025--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced ...
To determine the association of a central-line maintenance team on the incidence of central-line-associated bloodstream infections (CLABSIs) in the neonatal intensive care unit (NICU). Overall CLABSI ...
April 27, 2012 (Phoenix, Arizona) — The rate of inappropriately placed central venous catheters (CVCs) substantially declines when residents and emergency department (ED) technicians are trained to ...
Whether through the use of alcohol-containing caps or basic cleaning of the injection port of the central line, infection preventionists at three hospitals are finding successful ways to stop germs ...
Totally implantable vascular access device (TIVAD)-related complications interfere in the anticancer treatment and increase medical expenses. We examined whether the implantation side of central line ...
“Our research shows that incorporating a line guard into our infection-prevention protocols can deliver meaningful benefits for children requiring central line access.” “The publication of this study ...
Anaheim, Calif., June 5, 2014 – Whether through the use of alcohol-containing caps or basic cleaning of the injection port of the central line, infection preventionists at three hospitals are finding ...
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the publication of results from a peer-reviewed clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback